Literature DB >> 3518989

Induction of drug-metabolizing enzymes: mechanisms and consequences.

A B Okey, E A Roberts, P A Harper, M S Denison.   

Abstract

The activity of many enzymes that carry out biotransformation of drugs and environmental chemicals can be substantially increased by prior exposure of humans or animals to a wide variety of foreign chemicals. Increased enzyme activity is due to true enzyme induction mediated by increased synthesis of mRNAs which code for specific drug-metabolizing enzymes. Several species of cytochrome P-450 are inducible as are certain conjugating enzymes such as glutathione S-transferases, glucuronosyl transferases, and epoxide hydrolases. Induction of drug-metabolizing enzymes has been shown in several instances to alter the efficacy of some therapeutic agents. Induction of various species of cytochrome P-450 also is known to increase the rate at which potentially toxic reactive metabolic intermediates are formed from drugs or environmental chemicals. Overall, however, induction of drug-metabolizing enzymes appears to be a beneficial adaptive response for organisms living in a "chemically-hostile" world.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518989     DOI: 10.1016/s0009-9120(86)80060-1

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  13 in total

1.  Evolutionarily divergent electron donor proteins interact with P450MT2 through the same helical domain but different contact points.

Authors:  H K Anandatheerthavarada; G Amuthan; G Biswas; M A Robin; R Murali; M R Waterman; N G Avadhani
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Formation and characterization of three dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications.

Authors:  Poonam Verma; Vipin Verma; Pratima Ray; Alok R Ray
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-20       Impact factor: 2.416

3.  Exposure to toluene increases the urinary excretion of D-glucaric acid.

Authors:  A Moretto; M Lotti
Journal:  Br J Ind Med       Date:  1990-01

4.  Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.

Authors:  C Funck-Brentano; H K Kroemer; H Pavlou; R L Woosley; D M Roden
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

5.  Accumulation of mitochondrial P450MT2, NH(2)-terminal truncated cytochrome P4501A1 in rat brain during chronic treatment with beta-naphthoflavone. A role in the metabolism of neuroactive drugs.

Authors:  E Boopathi; H K Anandatheerthavarada; S V Bhagwat; G Biswas; J K Fang; N G Avadhani
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

6.  Induction of P-450 in workers exposed to dioxin.

Authors:  W Halperin; W Kalow; M H Sweeney; B K Tang; M Fingerhut; B Timpkins; K Wille
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

7.  Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats.

Authors:  S A Wrighton; P E Thomas; P Willis; S L Maines; P B Watkins; W Levin; P S Guzelian
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

8.  Induction potential of fluconazole toward drug-metabolizing enzymes in rats.

Authors:  K L Lavrijsen; J M Van Houdt; D M Van Dyck; W E Meuldermans; J J Heykants
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

Review 9.  Genetic variation in the human hepatic cytochrome P-450 system.

Authors:  W Kalow
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.